Study design features affecting outcome in antidepressant trials.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Affective Disorders

• Publication date

  2012-12-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jad.2012.03.021PMID 22658811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.

  2011cited by this paper
• The ClinicalTrials.gov results database--update and key issues.

  2011cited by this paper
• Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

  2010cited by this paper
• Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.

  2010cited by this paper
• The Perfect Storm: CNS Drug Development in Trouble

  2010cited by this paper
• Antidepressant drug effects and depression severity: a patient-level meta-analysis.

  2010cited by this paper
• All the relevant data?

  2010cited by this paper
• Trial design issues and treatment effect modeling in multi‐regional schizophrenia trials

  2010cited by this paper
• Something Borrowed, Something Blue: Why is Bipolar Disorder an Orphan?

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Does Study Design Influence Outcome?

  2009influential reference
• Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications

  2009cited by this paper
• Standardizing the Hamilton Depression Rating Scale: past, present, and future

  2009cited by this paper
• Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

  2009cited by this paper
• Ethical and scientific implications of the globalization of clinical research.

  2009cited by this paper
• Selective publication of antidepressant trials and its influence on apparent efficacy.

  2008influential reference
• Isn’t the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008

  2008cited by this paper
• Trends in the globalization of clinical trials

  2008cited by this paper
• Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

  2008influential reference
• Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.

  2007cited by this paper
• Clinical trials and the response rate illusion.

  2007cited by this paper
• Efficacy of moclobemide in different patient groups: a meta-analysis of studies

  2005cited by this paper
• Frequency of Positive Studies Among Fixed and Flexible Dose Antidepressant Clinical Trials: An Analysis of the Food and Drug Administraton Summary Basis of Approval Reports

  2003cited by this paper
• Clinical trials of antidepressant medications are producing meaningless results

  2003cited by this paper
• Ethnic Factors in the Acceptability of Foreign Clinical Data

  1998cited by this paper
• Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.

  1997cited by this paper
• Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders.

  1996cited by this paper
• The Inventory of Depressive Symptomatology (IDS): psychometric properties

  1996cited by this paper
• Moclobemide and tricyclic antidepressants in severe depression: meta-analysis and prospective studies.

  1995cited by this paper
• The Hamilton Scales and the Hopkins Symptom Checklist (SCL–90)

  1992cited by this paper
• Residual effects of hypnotics: an update.

  1991cited by this paper
• Dosing strategies for antidepressant agents.

  1991cited by this paper
• Inadequate Dosing and Pharmacokinetic Variability as Confounding Factors in Assessment of Efficacy of Antidepressants

  1990cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper
• Development of a rating scale for primary depressive illness.

  1967cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Nocebo and lessebo effects.

  2020cites this paper
• Nocebo and lessebo effects

  2020cites this paper
• Design considerations for handling dropouts in anti-depressant drug trials.

  2018cites this paper
• Declining efficacy in controlled trials of antidepressants: effects of placebo dropout.

  2014influential citation
• Another face of placebo: The lessebo effect in Parkinson disease

  2014cites this paper
• Bias , with a Focus on Psychiatry : Causes and Solutions

  2013cites this paper
• Publication Bias, with a Focus on Psychiatry: Causes and Solutions

  2013cites this paper
• Aktuelle ethische Fragen in der Depressionsforschung

  2013cites this paper